PAP-1 is a potent, selective, and orally active Kv1.3 blocker (EC50 = 2 nM); it inhibits Kv1.3 in a use-dependent manner by preferentially binding to the channel's C-type inactivated state; it exhibits 23-fold selectivity over Kv1.5 (EC50 = 45 nM) and 33- to 125-fold selectivity over other Kv1 family channels; it shows no cytotoxicity or phototoxicity.